GI
GH icon

Gradient Investments’s Guardant Health GH Stock Holding History

Gradient Investments’s Portfolio GH Stock Details GH Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2022
Q2 		– Sell
-50
Closed -$3K – 1274
2022
Q1 		$3K Sell
50
-100
-67% -$6.84K ﹤0.01% 973
2021
Q4 		$15K Buy
150
+100
+200% +$10.3K ﹤0.01% 710
2021
Q3 		$6K Hold
50
– – ﹤0.01% 855
2021
Q2 		$6K Hold
50
– – ﹤0.01% 846
2021
Q1 		$8K Hold
50
– – ﹤0.01% 805
2020
Q4 		$6K Hold
50
– – ﹤0.01% 780
2020
Q3 		$6K Hold
50
– – ﹤0.01% 787
2020
Q2 		$4K Sell
50
-7
-12% -$564 ﹤0.01% 773
2020
Q1 		$4K Buy
57
+7
+14% +$537 ﹤0.01% 805
2019
Q4 		$4K Hold
50
– – ﹤0.01% 850
2019
Q3 		$3K Hold
50
– – ﹤0.01% 869
2019
Q2 		$4K Buy
+50
New +$3.82K ﹤0.01% 795

Other funds holding GH

Fidelity Investments
Fidelity Investments Boston, Massachusetts $2.3T AUM 54.33% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
Capital International Investors
Capital International Investors Los Angeles, California $484B AUM 34.9% 1-Year Est. Return
BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
Morgan Stanley
Morgan Stanley New York $1.89T AUM 35.08% 1-Year Est. Return
Viking Global Investors
Viking Global Investors Stamford, Connecticut $35.1B AUM 21.36% 1-Year Est. Return
ClearBridge Investments
ClearBridge Investments New York $121B AUM 27.52% 1-Year Est. Return
Franklin Resources
Franklin Resources San Mateo, California $462B AUM 39.16% 1-Year Est. Return
Capital Research Global Investors
Capital Research Global Investors Los Angeles, California $717B AUM 35.42% 1-Year Est. Return
CS
Credit Suisse Zurich, Switzerland $104B AUM 34.76% 1-Year Est. Return

Gradient Investments's GH Position: Q2 2022 in Review

Gradient Investments sold out of Guardant Health (GH) in Q2 2022, closing a stake of 50 shares — an estimated $3K sold.

Gradient Investments first reported a position in GH in Q2 2019 and held it in 12 quarters. The position peaked at $15K in Q4 2021. 332 funds tracked by Wall St. Rank hold GH as of Q2 2022.

  • Gradient Investments reported no remaining Guardant Health position as of Q2 2022 after selling out during the quarter.
  • Gradient Investments sold 50 Guardant Health shares in Q2 2022, an estimated $3K.
  • Gradient Investments first reported a position in Guardant Health in Q2 2019 and held it in 12 quarters.
  • Gradient Investments's Guardant Health position peaked at $15K in Q4 2021.
  • 332 funds tracked by Wall St. Rank held Guardant Health as of Q2 2022.

Based on Gradient Investments's 13F filing for Q2 2022, filed 11 Jul 2022.